Personal information

Activities

Employment (8)

Virginia Commonwealth University: Richmond, VA, US

2023 to present | Associate Professor (Department of Pharmacology and Toxicology)
Employment
Source: Self-asserted source
Emmanuel Skordalakes

University of Pennsylvania: Philadelphia, PA, US

2012 to 2022 | Adjunct Associate Professor (Chemistry)
Employment
Source: Self-asserted source
Emmanuel Skordalakes

University of Pennsylvania: Philadelphia, PA, US

2012 to 2022 | Adjunct Associate Professor (Biochemistry and Biophysics)
Employment
Source: Self-asserted source
Emmanuel Skordalakes

The Wistar Institute: Philadelphia, US

2012 to 2022 | Associate Professor
Employment
Source: Self-asserted source
Emmanuel Skordalakes

University of Pennsylvania: Philadelphia, PA, US

2008 to 2011 | Adjunct Assistant Professor (Chemistry )
Employment
Source: Self-asserted source
Emmanuel Skordalakes

Wistar Institute: Philadelphia, PA, US

2007 to 2011 | Assistant Professor (Gene Expression and Regulation)
Employment
Source: Self-asserted source
Emmanuel Skordalakes

University of Pennsylvania: Philadelphia, PA, US

2007 to 2011 | Adjunct Assistant professor (Biochemistry and Biophysics)
Employment
Source: Self-asserted source
Emmanuel Skordalakes

Thrombosis Research Institute: London, London, GB

1993 to 1994 | Synthetic Chemistry Trainee (Peptide Synthesis Division)
Employment
Source: Self-asserted source
Emmanuel Skordalakes

Education and qualifications (4)

University of California Berkeley: Berkeley, CA, US

2001 to 2006 | PostDoc (Molecular and Cellular Biology)
Education
Source: Self-asserted source
Emmanuel Skordalakes

Imperial College London & MRC: London, GB

1995 to 2000 | PhD (Structural Biology)
Education
Source: Self-asserted source
Emmanuel Skordalakes

University College London: London, GB

1991 to 1992 | MSc (Chemistry)
Education
Source: Self-asserted source
Emmanuel Skordalakes

Anglia Ruskin University - Cambridge Campus: Cambridge, Cambridgeshire, GB

1987 to 1990 | BSc (Chemistry Major/Biology)
Education
Source: Self-asserted source
Emmanuel Skordalakes

Funding (2)

Targeting telomerase for melanoma therapeutics

2016-08 to 2021-07 | Grant
NATIONAL CANCER INSTITUTE (Bethesda, US)
GRANT_NUMBER:

1R01CA201312-01A1

Source: Self-asserted source
Emmanuel Skordalakes

Structural and Biochemical Analysis of Telomerase Function

2010-06-01 to 2015-05-31 | Grant
National Institute of General Medical Sciences (Bethesda, US)
GRANT_NUMBER: 5R01GM088332-05
GRANT_NUMBER: 5R01GM088332-05
Source: Self-asserted source
Emmanuel Skordalakes via DimensionsWizard

Peer review (1 review for 1 publication/grant)

Review activity for Nature communications (1)